---
title: "Parabolic Drugs Ltd (PARABDRUGS) — Share Price, Financials & Analysis"
symbol: "PARABDRUGS"
company: "Parabolic Drugs Ltd"
canonical: "https://tapetide.com/stocks/PARABDRUGS"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
generated_at: "2026-09-13T18:47:53.433Z"
---

# Parabolic Drugs Ltd (PARABDRUGS)

Canonical page: https://tapetide.com/stocks/PARABDRUGS

## Company

- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** parabolicdrugs.com

## About

Parabolic Drugs engages in the manufacture and contract manufacture of active pharmaceutical ingredients (API) and API intermediates.

## Latest Price

## Key Insights

### Strengths

- Company has reduced debt.

### Weaknesses

- Company has low interest coverage ratio.

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| net income growth | 12% | 20% | 14% |
| revenue growth | -100% | — | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 16.23 | 12.85 | 4.97 | 0.26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 19.37 | 17.71 | 10.9 | 2.27 | 1.95 | 1.95 | 1.71 | 1.71 | 1.71 | 1.71 | 0.44 | 0.84 |
| Operating Profit | -3.14 | -4.86 | -5.93 | -2.01 | -1.95 | -1.95 | -1.71 | -1.71 | -1.71 | -1.71 | -0.44 | -0.84 |
| OPM % | -19.35 | -37.82 | -119.32 | -773.08 | — | — | — | — | — | — | — | — |
| Other Income | 0.02 | 0.13 | 0.66 | 0.01 | -1.88 | 0.01 | 0 | 0 | 0 | 0 | 0.27 | 0.23 |
| Interest | 2.09 | 1.26 | 2.7 | 0.05 | -0.54 | 0.16 | 0.17 | 0.17 | 0.17 | 0.17 | 0.46 | 0.34 |
| Depreciation | 8.59 | 5.73 | 5.67 | 5.14 | 5.97 | 5.56 | 5.34 | 5.34 | 5.34 | 5.34 | 4.85 | 5.1 |
| Profit before tax | -13.8 | -11.72 | -13.64 | -7.19 | -9.26 | -7.66 | -7.22 | -7.22 | -7.22 | -7.22 | -5.48 | -6.05 |
| Tax % | 3.41 | -10.24 | 5.21 | -1.39 | 1.84 | -2.22 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -14.27 | -10.52 | -14.35 | -7.09 | -9.43 | -7.49 | -7.22 | -7.22 | -7.22 | -7.22 | -5.48 | -6.05 |
| EPS in Rs | -2.31 | -1.7 | -2.32 | -1.15 | -1.52 | -1.21 | -1.17 | -1.17 | -1.17 | -1.17 | -0.89 | -0.98 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 919 | 763 | 438 | 231 | 75 | 73 | 71 | 18 | 0 | 0 |
| Expenses | 762 | 836 | 519 | 310 | 381 | 118 | 87 | 33 | 6 | 5 |
| Operating Profit | 157 | -73 | -82 | -78 | -306 | -46 | -15 | -15 | -6 | -5 |
| OPM % | 17 | -10 | -19 | -34 | -410 | -62 | -22 | -82 | — | — |
| Other Income | 4 | 6 | 13 | 1 | 0 | 4 | 4 | -1 | 0 | 0 |
| Interest | 64 | 73 | 83 | 99 | 108 | 10 | 9 | 3 | 1 | 1 |
| Depreciation | 31 | 55 | 68 | 73 | 67 | 53 | 35 | 23 | 22 | 21 |
| Profit before tax | 66 | -195 | -220 | -249 | -481 | -105 | -55 | -42 | -29 | -26 |
| Tax % | 23 | -28 | -40 | 52 | 1 | 3 | 3 | -1 | 0 | — |
| Net Profit | 51 | -140 | -132 | -379 | -485 | -108 | -57 | -41 | -29 | -26 |
| EPS in Rs | 8.27 | -22.58 | -21.28 | -61.29 | -78.39 | -17.46 | -9.21 | -6.69 | -4.63 | -4.21 |
| Dividend Payout % | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 62 | 62 | 62 | 62 | 62 | 62 | 62 | 62 | 62 | 62 |
| Reserves | 367 | 239 | 121 | -258 | -743 | -851 | -908 | -949 | -977 | -990 |
| Borrowings | 555 | 777 | 842 | 957 | 972 | 979 | 984 | 985 | 157 | 158 |
| Other Liabilities | 331 | 161 | 202 | 189 | 287 | 303 | 281 | 275 | 1108 | 1109 |
| Total Liabilities | 1314 | 1239 | 1227 | 950 | 577 | 493 | 419 | 372 | 349 | 339 |
| Fixed Assets | 188 | 334 | 331 | 395 | 371 | 349 | 326 | 298 | 278 | 267 |
| CWIP | 187 | 72 | 81 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Investments | 4 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Other Assets | 936 | 827 | 809 | 542 | 193 | 132 | 80 | 62 | 59 | 59 |
| Total Assets | 1314 | 1239 | 1227 | 950 | 577 | 493 | 419 | 372 | 349 | 339 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 3 | 207 | -111 | 28 | -4 | 90 | 2 | 3 | — | — |
| Cash from Investing Activity | -180 | -205 | -108 | -30 | -16 | 1 | 0 | 1 | — | — |
| Cash from Financing Activity | 186 | 7 | 197 | -4 | 17 | -93 | -2 | -4 | — | — |
| Net Cash Flow | 8 | 9 | -23 | -6 | -3 | -2 | 0 | 0 | — | — |
| Free Cash Flow | -110 | 97 | -158 | 3 | -17 | 91 | 2 | 4 | — | — |
| CFO/OP | 17 | 140 | 151 | -1 | 5 | -29 | -4 | -20 | — | — |

### Ratios

| Item | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 163 | 88 | 66 | 124 | 155 | 342 | 335 | 148 | 562 | — |
| Inventory Days | 276 | 237 | 167 | 363 | 450 | 45 | 61 | 91 | 12 | — |
| Days Payable | 137 | 149 | 59 | 187 | 146 | 104 | 420 | 465 | 1325 | — |
| Cash Conversion Cycle | 302 | 176 | 174 | 301 | 460 | 283 | -24 | -226 | -751 | — |
| Working Capital Days | 50 | 5 | 36 | 45 | -169 | -1708 | -1483 | -1620 | -6735 | — |
| ROCE % | 15 | 14 | -12 | -13 | -17 | -71 | -39 | -28 | -31 | — |

## Shareholding Pattern

### annual

| Category | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Dec 2020 |
| --- | --- | --- | --- | --- | --- |
| Promoters | 37.8% | 37.79% | 37.79% | 37.79% | 37.79% |
| FIIs | 8.06% | 8.06% | 8.06% | 8.06% | 8.06% |
| DIIs | 0.58% | 0.58% | 0.58% | 0.58% | 0.58% |
| Public | 53.56% | 53.57% | 53.57% | 53.57% | 53.57% |
| No. of Shareholders | 14547 | 13132 | 12899 | 12885 | 13652 |

### Quarterly

| Category | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 37.79% | 37.79% | 37.79% | 37.79% | 37.79% | 37.79% | 37.79% | 37.79% | 37.79% | 37.79% | 37.79% | 37.79% |
| FIIs | 8.06% | 8.06% | 8.06% | 8.06% | 8.06% | 8.06% | 8.06% | 8.06% | 8.06% | 8.06% | 8.06% | 8.06% |
| DIIs | 0.58% | 0.58% | 0.58% | 0.58% | 0.58% | 0.58% | 0.58% | 0.59% | 0.58% | 0.58% | 0.58% | 0.58% |
| Public | 53.57% | 53.57% | 53.57% | 53.57% | 53.57% | 53.57% | 53.57% | 53.56% | 53.57% | 53.57% | 53.57% | 53.57% |
| No. of Shareholders | 13132 | 13095 | 13044 | 12959 | 12899 | 12824 | 12794 | 12867 | 12885 | 13226 | 13360 | 13652 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 2 / 5 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 255.36 | Sell |
| EMA (10) | 254.06 | Sell |
| SMA (20) | 264.67 | Sell |
| EMA (20) | 261.5 | Sell |
| SMA (50) | 279.8 | Sell |
| EMA (50) | 277.32 | Sell |
| SMA (100) | 297.87 | Sell |
| EMA (100) | 296.87 | Sell |
| SMA (200) | 335.37 | Sell |
| EMA (200) | 324.22 | Sell |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 32.78 | Neutral |
| MACD (12,26,9) | -9.34 | Sell |
| Stochastic (14,3,3) | 19.84 | Buy |
| ADX (14) | 28.41 | Buy |
| Williams %R (14) | -76.44 | Neutral |
| ATR (14) | 9.72 | High Volatility |
| ROC (12) | -8.66 | Sell |
| Stoch RSI (14) | 32.05 | Neutral |
| UO (7,14,28) | 42.03 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 8 Feb 2021 - This is in reference to the captioned matter and as per the Resolution Plan approved by Hon'ble National Company Law Tribunal, Chandigarh Bench ('NCLT') in … | [Corporate Insolvency Resolution Process (CIRP)-Public Announcement 8 Feb 2021 - This is in reference to the captioned matter and as per the Resolution Plan approved by Hon'ble National Company Law Tribunal, Chandigarh Bench ('NCLT') in …](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b08fdc53-3325-4ff0-b2be-7cb07f849b05.pdf) |
| 8 Feb 2021 - In reference to the captioned matter and as per the Resolution Plan approved by Hon'ble National Company Law Tribunal, Chandigarh Bench ('NCLT') in terms of … | [Corporate Insolvency Resolution Process (CIRP)-Public Announcement 8 Feb 2021 - In reference to the captioned matter and as per the Resolution Plan approved by Hon'ble National Company Law Tribunal, Chandigarh Bench ('NCLT') in terms of …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b08fdc53-3325-4ff0-b2be-7cb07f849b05.pdf) |
| 22 Jan 2021 - Depositories and Participants) Regulations, 2018, please find enclosed herewith the certificate received from Link Intime India Private Limited (herein called as 'RTA') for the Quarter … | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 22 Jan 2021 - Depositories and Participants) Regulations, 2018, please find enclosed herewith the certificate received from Link Intime India Private Limited (herein called as 'RTA') for the Quarter …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/75b42d72-76ae-4a13-9e2f-51811a1bb374.pdf) |
| 22 Jan 2021 - As per Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018, please find enclosed herewith the certificate received from Link Intime India Private … | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 22 Jan 2021 - As per Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018, please find enclosed herewith the certificate received from Link Intime India Private …](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75b42d72-76ae-4a13-9e2f-51811a1bb374.pdf) |
| — | [Outcome Of Board Meeting Held On 11.02.2021 And Intimation Of Financial Results For The Quarter And Nine Months Ended 31.122020 11 Feb 2021](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9359b4a6-ff7b-41eb-9248-d094e95704f1.pdf) |
| — | [Outcome Of Board Meeting Held On 11.02.2021 And Intimation Of Financial Results For The Quarter And Nine Months Ended 31.122020 11 Feb 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9359b4a6-ff7b-41eb-9248-d094e95704f1.pdf) |
| — | [Board Meeting Intimation for Un-Audited Quarterly Financial Results For The Quarter And Nine Months Ended On 31St December, 2020 5 Feb 2021](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a62c4a1-e597-49c1-a9bd-246f30eb4d60.pdf) |
| — | [Board Meeting Intimation for Un-Audited Quarterly Financial Results For The Quarter And Nine Months Ended On 31St December, 2020 5 Feb 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7a62c4a1-e597-49c1-a9bd-246f30eb4d60.pdf) |
| — | [Fixation Of 'Record Date' For Suspension Of Trading Of Units/Scrip 25 Jan 2021](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=183f4af2-f958-49de-9480-d190e122f983.pdf) |
| — | [Fixation Of 'Record Date' For Suspension Of Trading Of Units/Scrip 25 Jan 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/183f4af2-f958-49de-9480-d190e122f983.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2010 from nse](https://archives.nseindia.com/annual_reports/AR_PARABDRUGS_2009_2010_13062011102530.zip) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/533211/5332110318.pdf) |
| from bse | [Annual Report 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/533211/5332110317.pdf) |
| from bse | [Annual Report 2016 from bse](https://www.bseindia.com/bseplus/AnnualReport/533211/5332110316.pdf) |
| from bse | [Annual Report 2015 from bse](https://www.bseindia.com/bseplus/AnnualReport/533211/5332110315.pdf) |
| from bse | [Annual Report 2014 from bse](https://www.bseindia.com/bseplus/AnnualReport/533211/5332110314.pdf) |
| from bse | [Annual Report 2013 from bse](https://www.bseindia.com/bseplus/AnnualReport/533211/5332110313.pdf) |
| from bse | [Annual Report 2012 from bse](https://www.bseindia.com/bseplus/AnnualReport/533211/5332110312.pdf) |
| from bse | [Annual Report 2011 from bse](https://www.bseindia.com/bseplus/AnnualReport/533211/5332110311.pdf) |
| from bse | [Annual Report 2010 from bse](https://www.bseindia.com/bseplus/AnnualReport/533211/5332110310.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:47:53.433Z.